Diabetes is a chronic metabolic condition characterized by high or low blood glucose (or blood sugar) levels, leading to significant damage to the heart, blood vessels, eyes, kidneys, and nerves over time. The rationale behind developing diabetes incorporates two factors: insufficient insulin production (produced by the pancreas and reduced blood glucose) or unsatisfactory cell response to insulin action.
Get FREE sample copy at:
The Type 2 Diabetes market report also covers emerging drugs, current treatment practices, Type 2 Diabetes market share of the individual therapies, current and forecasted Type 2 Diabetes Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Type 2 Diabetes treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Type 2 Diabetes Market Key Facts
Type 2 diabetes is often milder than type 1. But it can still cause major health complications, especially in the tiny blood vessels in the kidneys, nerves, and eyes. Type 2 also raises the risk of heart disease and stroke.
More than 34 million Americans have diabetes (about 1 in 10), and approximately 90-95% of them have type 2 diabetes. Type 2 diabetes most often develops in people over age 45, but more and more children, teens, and young adults are also developing it (Centers for Disease Control and Prevention, n.d.).
Based on the weighted NHIS population, the estimated numbers of adults with type 1, type 2, and other diabetes types were 1.3 million, 21.0 million, and 0.8 million, respectively.
Key Benefits of Type 2 Diabetes Market Report
Type 2 Diabetes market report provides an in-depth analysis of Type 2 Diabetes Market Size, Share, and Trend for 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
The Type 2 Diabetes market report will help in developing business strategies by understanding the Type 2 Diabetes Market trends & developments, key players, and future market competition that will shape and drive the Type 2 Diabetes market in the upcoming years.
The Type 2 Diabetes market report covers Type 2 Diabetes current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Type 2 Diabetes market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Type 2 Diabetes market size is anticipated to increase during the study period owing to the increasing prevalent population of Diabetes and the expected launch of emerging drugs in the 7MM.
The Type 2 Diabetes market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Type 2 Diabetes market trends by analysing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Type 2 Diabetes market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Type 2 Diabetes Epidemiology
The Type 2 Diabetes epidemiology section covers insights about the historical and current Type 2 Diabetes patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Type 2 Diabetes Drugs Uptake and Key Market Players
The Type 2 Diabetes Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Type 2 Diabetes market or expected to get launched in the market during the study period. The analysis covers Type 2 Diabetes market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The available therapeutics treatment options in the Type 2 diabetes landscape aim to provide a cure to the patients suffering from this indication; however, there are several challenges that are yet to be tackled.
The Type 2 Diabetes market size is anticipated to be driven in the coming years due to the rise in novel drugs and therapies and increased healthcare spending across the world. The high prevalence of the disease and participation of the key players will augur a change in the market dynamics.
Type 2 Diabetes Companies:
Eli Lilly and Company
And many others.
Type 2 Diabetes Therapies Covered in the report include:
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Type 2 Diabetes Competitive Intelligence Analysis
4. Type 2 Diabetes Market Overview at a Glance
5. Type 2 Diabetes Disease Background and Overview
6. Type 2 Diabetes Patient Journey
7. Type 2 Diabetes Epidemiology and Patient Population
8. Type 2 Diabetes Treatment Algorithm, Current Treatment, and Medical Practices
9. Type 2 Diabetes Unmet Needs
10. Key Endpoints of Type 2 Diabetes Treatment
11. Type 2 Diabetes Marketed Products
12. Type 2 Diabetes Emerging Therapies
13. Type 2 Diabetes Seven Major Market Analysis
14. Attribute Analysis
15. Type 2 Diabetes Market Outlook (7 major markets)
16. Type 2 Diabetes Access and Reimbursement Overview
17. KOL Views on the Type 2 Diabetes Market.
18. Type 2 Diabetes Market Drivers
19. Type 2 Diabetes Market Barriers
21. DelveInsight Capabilities
*The table of contents is not exhaustive; the final content may vary.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States